Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

13.62 -0.18 (-1.27%)
Streaming Delayed Price Updated: 12:55 PM EDT, Jul 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers. 
Via StockStory
Topics Economy
Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks
Looking back on research tools & consumables stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Sotera Health Company (NASDAQ:SHC) and its peers. 
Via StockStory
Topics Economy
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bruker (NASDAQ:BRKR) and its peers. 
Via StockStory
Topics Economy
Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers. 
Via StockStory
Topics Economy
Beyond The Numbers: 5 Analysts Discuss Avantor Stock
 
Via Benzinga
Avantor Q4 Earnings Report: What Investors Need to Know
 
Via Benzinga
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst... 
Via StockStory
Topics Economy
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSE:RVTY) and the best and worst... 
Via StockStory
Topics Economy
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers. 
Via Benzinga
Estee Lauder, Moderna And PayPal Are Among Top 10 Large Cap Losers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
Skyworks Solutions, Estee Lauder, Venture Global, Neurocrine Biosciences, Moderna, Illumina, IDEX Corporation, PTC Inc, PayPal Holdings, Skechers U.S.A. and Avantor were worst performers, fell up to... 
Via Benzinga
(AVTR) - Analyzing Avantor's Short Interest
 
Via Benzinga
What Analysts Are Saying About Avantor Stock
 
Via Benzinga
Why Avantor (AVTR) Stock Is Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 9.4% in the afternoon session after the company reported weak fourth quarter results. Its revenue missed and its organic revenue fell slightly... 
Via StockStory
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday?
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite. 
Via Benzinga
Topics Economy World Trade
How Is The Market Feeling About Avantor?
 
Via Benzinga
(AVTR) - Analyzing Avantor's Short Interest
 
Via Benzinga
(AVTR) - Analyzing Avantor's Short Interest
 
Via Benzinga
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
Avantor's Q4 net sales missed estimates, but adjusted EPS beat expectations. The company projects 2025 organic revenue growth and stronger free cash flow. 
Via Benzinga
Topics Earnings
Avantor (NYSE:AVTR) Misses Q4 Sales Targets, Stock Drops
Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 2.1% year on year to $1.69 billion. Its non-GAAP profit of $0.27 per share was... 
Via StockStory
Earnings Scheduled For February 7, 2025
 
Via Benzinga
Avantor Earnings: What To Look For From AVTR
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
How Is The Market Feeling About Avantor?
 
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Avantor
 
Via Benzinga
A Look Ahead: Avantor's Earnings Forecast
 
Via Benzinga
P/E Ratio Insights for Avantor
 
Via Benzinga
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
Quantum-Si partners with NVIDIA to advance AI-powered proteomics, collaborates with Avantor for U.S. and Canada distribution of protein sequencing tech. 
Via Benzinga
What 11 Analyst Ratings Have To Say About Avantor
 
Via Benzinga
AVANTOR INC is showing promising signs of setting up for a breakout.
AVANTOR INC (NYSE:AVTR) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
Peering Into Avantor's Recent Short Interest
 
Via Benzinga
Technical Insights for AVANTOR INC (NYSE:AVTR): Is a Breakout Imminent?
With a solid technical rating of 10 out of 10, AVANTOR INC (NYSE:AVTR) is showing strong indications of a possible breakout. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.